Jia Luo

机构：XinHua Hospital · ORCID：0000-0003-2796-358X

发表论文 147 篇 · 总被引 2922 次 · h-index 28

代表论文

• Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial (2025 · The Lancet Oncology · 被引 49)
• Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors (2024 · Annals of Oncology · 被引 27)
• 6MO: Safety and clinical activity of daraxonrasib (RMC-6236) in RAS mutant non-small cell lung cancer (NSCLC) (2025 · Journal of Thoracic Oncology · 被引 20)
• Dynamic interface engineering of softening metal-inorganic framework for dendrite-free zinc anodes (2025 · Energy storage materials · 被引 5)
• Chinese multicenter expert consensus on the diagnosis and treatment of hilar cholangiocarcinoma: 2025 edition (2025 · BioScience Trends · 被引 5)
• International guidelines on the diagnosis and treatment of NUT carcinoma (2025 · The Innovation · 被引 5)